Hapag-Lloyd AG (0RCG)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 133.20 |
|---|---|
| 52-week range | 106.01 – 155.12 |
| Return, 1 month / 3 months | −2.0% / +4.0% |
| Return, 1 year / 3 years | +16.8% / +2.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 45 |
| Volatility (1 year) | 39.7% |
| Worst drawdown (1 year) | -30.5% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hapag-Lloyd is a container shipping company based in Hamburg, Germany. It moves freight for customers around the world using a fleet of container ships on regular liner services linking ports across continents. Its customers include manufacturers, retailers and freight forwarders who need goods transported by sea, and the company also offers related services such as container handling and inland transport connections to support those ocean voyages.
The shares are listed on the London Exchange in UK under the code 0RCG, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hapag-Lloyd AG (0RCG) trades on the London Exchange in UK. It last closed at EUR 133.20 on 21 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 1,838 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.8% and over the last three months it rose 4.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.7% | ||
| From 52-week high | -13.5% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 4.0% | ||
| 6-month return | 18.2% | ||
| 12-month return, skipping the last month | 19.2% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.5% | ||
| Liquidity | 18 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | −2.0% |
| 3 months | +4.0% |
| 6 months | +18.2% |
| 1 year | +16.8% |
| 3 years | +2.7% |
| 5 years | +18.6% |
Signals
| 50-day / 200-day average | 135.07 / 123.69 |
|---|---|
| Golden / death cross (60 days) | Golden, 56 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 May 2026 | EUR 3.0000 |
| 2 May 2025 | EUR 8.2000 |
| 2 May 2024 | EUR 9.2500 |
| 4 May 2023 | EUR 63.0000 |
| 26 May 2022 | EUR 35.0000 |
| 31 May 2021 | EUR 3.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.